Effects of AS2541019, a novel selective PI3Kδ inhibitor, on antibody production and hamster to rat xenotransplantation
Takanori Marui(Astellas Pharma (Japan)), Tatsuaki Morokata(Astellas Pharma (Japan)), Sunao Imada(Astellas Pharma (Japan)), Misato Ito(Fukushima Medical University), Tomoko Kawashima(Astellas Pharma (Japan)), Yoko Kaneko(Keio University), Masahiko Akamatsu(Astellas Pharma (Japan)), Fumie Takahashi(Astellas Pharma (Japan)), Hidehiko Fukahori(Astellas Pharma (Japan))
Cited by 4
Related Papers
NAK is an IκB kinase-activating kinase
|Nature|2000|374
STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells
|Oncogene|2004|306
Growth arrest‐specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway
|Molecular Carcinogenesis|2006|108
Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53
|Journal of Biological Chemistry|1999|100